Cancer Progress 2020 Panels:

Inflecting Value in Early Stage Biotech ( in an Increasingly Cost Conscious Environment): Linking Proof of Relevance to Pricing & Reimbursement

Next Wave of Diagnostics, Including Precision IO: Early and Smarter, the Better to Cure

Vaccines: From Paleo to Neo, Cancer Vaccines in the New Age of IO

Investing into Oncology: Who, What and Where?

Paradigm-shifting platforms II, Non-IO: Targeting Better, Targeting the Intractable

Paradigm-shifting platforms I, IO: Taking IO to the next Level